Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02647645 · ClinicalTrials.gov registry record · NA
Cognitive Training With and Without tDCS to Improve Cognition in HIV
A NA study, sponsored by Nova Southeastern University.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02647645: Clinical Trial NA study, sponsored by Nova Southeastern University.
NCT02647645 is a NA study that was terminated before completion, run by Nova Southeastern University. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02647645, a NA study, was terminated before completion, sponsored by Nova Southeastern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to develop pilot data on the potential efficacy of computer-based cognitive training or the combination of computer-based cognitive training with transcranial direct current stimulation (tDCS) in improving cognitive function in persons with HIV-related mild neurocognitive disorder (MND).
Primary Outcome
Participants' rate of improvement on a verbal working memory task. Participants completed a battery of cognitive measures administered by an evaluator blind to treatment assignment. We used the Digits Backward trial of the Digit Span subtest of the Wechsler Adult Intelligence Scale Fourth Edition (WAIS-IV; Pearson Assessment) to measure working memory. We used raw scores for analyses. These are the largest number of digits the participant could remember and repeat in reverse order. Possible rang
Interventions
- DEVICE Sham transcranial direct current stimulation
- DEVICE Transcranial direct current stimulation
- PROCEDURE Cognitive training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-05 |
| Phase | NA |
Why NCT02647645 stopped before completion
NCT02647645 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Sham transcranial direct current stimulation is the first listed.
NCT02647645 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02647645 about?
NCT02647645 is a clinical study titled "Cognitive Training With and Without tDCS to Improve Cognition in HIV". The purpose of this study is to develop pilot data on the potential efficacy of computer-based cognitive training or the combination of computer-based cognitive training with transcranial direct current stimulation (tDCS) in improving cognitive function in persons with HIV-related mild neurocognitiv...
What is the current status of trial NCT02647645?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2015-09. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02647645?
The interventions under investigation include: Sham transcranial direct current stimulation (DEVICE), Transcranial direct current stimulation (DEVICE), Cognitive training (PROCEDURE).
Who is sponsoring clinical trial NCT02647645?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02647645's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia